Proper benchmark needed for drug prices

Anne Nolan of IPHA claims (Letters, Nov 5) our branded drugs are at, or below, the European average.

Proper benchmark needed for drug prices

Ireland is broke, Spain is broke, so the cost of drugs in Spain should be the benchmark for us.

As a market we are an extension of the UK for all world manufacturers, so we could also benchmark against them. Maybe Anne could furnish a price list for Spain and UK for her IPHA-branded drugs and the Irish cost. The APMI could do the same for generics.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €130 €65

Best value

Monthly €12€6 / month

More in this section

Revoiced

Newsletter

Sign up to the best reads of the week from irishexaminer.com selected just for you.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited